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 Phosphorylation decelerates conformational dynamics
in bacterial translation elongation factors
Ariel Talavera,1,2* Jelle Hendrix,3,4* Wim Versées,1,2 Dukas Jurėnas,5 Katleen Van Nerom,5
Niels Vandenberk,3 Ranjan Kumar Singh,1,2 Albert Konijnenberg,1,2,6 Steven De Gieter,1,2
Daniel Castro-Roa,7 Anders Barth,8 Henri De Greve,1,2 Frank Sobott,6,9,10 Johan Hofkens,3,11
Nikolay Zenkin,7 Remy Loris,1,2† Abel Garcia-Pino5†
Bacterial protein synthesis is intricately connected to metabolic rate. One of the ways in which bacteria respond
to environmental stress is through posttranslational modifications of translation factors. Translation elongation
factor Tu (EF-Tu) is methylated and phosphorylated in response to nutrient starvation upon entering stationary
phase, and its phosphorylation is a crucial step in the pathway toward sporulation. We analyze how phospho-
rylation leads to inactivation of Escherichia coli EF-Tu. We provide structural and biophysical evidence that phos-
phorylation of EF-Tu at T382 acts as an efficient switch that turns off protein synthesis by decoupling nucleotide
binding from the EF-Tu conformational cycle. Direct modifications of the EF-Tu switch I region or modifications
in other regions stabilizing the b-hairpin state of switch I result in an effective allosteric trap that restricts the
normal dynamics of EF-Tu and enables the evasion of the control exerted by nucleotides on G proteins. These
results highlight stabilization of a phosphorylation-induced conformational trap as an essential mechanism for
phosphoregulation of bacterial translation and metabolism. We propose that this mechanism may lead to the
multisite phosphorylation state observed during dormancy and stationary phase.http
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Bacterial translation elongation is facilitated by three protein factors:
elongation factors Tu (EF-Tu), Ts (EF-Ts), andG (EF-G). EF-Tu brings
aminoacylated transfer RNAs (aa-tRNAs) to the ribosome. EF-Ts is a
guanosine diphosphate (GDP)/guanosine triphosphate (GTP) nucleo-
tide exchanger specific for EF-Tu, and EF-G is involved in the trans-
location of the translation ternary complex. These factors are under
intense regulation as cells sense and adjust their metabolic function in
response to variations in nutrient levels (1). EF-Tu, in particular, under-
goes a number of posttranslational modifications, which strongly in-
hibit protein synthesis. These modifications include acetylation,
methylation, and phosphorylation and can occur at several sites in
the protein (2–4). It has been shown that thesemodifications play cru-
cial roles in bacterial virulence, stress tolerance, dormancy, and sporo-
genesis (5–8).
Throughout the translation cycle, EF-Tu specifically binds aa-tRNAs,
guanine nucleotides, EF-Ts, and Mg2+. It also hydrolyzes GTP, an ac-
tivity that is significantly enhanced when bound to ribosomes. Besides
its pivotal role in protein biosynthesis, recent works suggest that EF-Tu
may alsomoonlight as a chaperone for diverse proteins (9–11). Not sur-
prisingly, several known antibiotics target the activity of EF-Tu (12).EF-Tu is a multidomain protein. The N-terminal domain (G do-
main) is a guanosine triphosphatase (GTPase) that is followed by two
b-barrel domains, important for aa-tRNA binding (13–15). G-domain
proteins generally function as molecular switches by alternating be-
tween inactive GDP-bound and active GTP-bound states (16). In the
case of EF-Tu, the GTP-bound or closed state is characterized by a
compact arrangement of all three domains that form a large interface
where the acceptor stem and the aminoacylated CCA tail of tRNAs
dock (15). In the GDP-bound or open state, its conformation is less
compact and is characterized by a large cavity between the three do-
mains. The conformational changes associated with hydrolysis of
GTP to GDP have a profound effect on aa-tRNA binding and on the
interaction of EF-Tu with the ribosome itself (17).
Bacterial EF-Tu is extensively modified during the different growth
states by phosphorylation, methylation, and acetylation with hyper-
modifications occurring in the stationary phase (5, 18–20). Phosphoryl-
ation of Escherichia coli EF-Tu at T382 was discovered more than
20 years ago (2), and since then, several other phosphorylation sites
have been described (18). It has been suggested that phosphorylation
at a single site is sufficient to inactivate EF-Tu and interfere with
translation elongation (2, 21). In Bacillus subtilis, phosphorylation of
EF-Tu at T65 and T385 also inhibits translation and plays an important
role in dormancy and sporogenesis (8). However, the mechanism by
which phosphorylation inactivates EF-Tu remains unknown. Although
one hypothesis states that phosphorylation of E. coli EF-Tu prevents it
from forming ternary aa-tRNA–GTP–EF-Tu complexes (22), exper-
iments on B. subtilis EF-Tu suggested that phosphorylation cripples
its GTPase activity and prevents the release of GTP–EF-Tu complexes
from the ribosome (8). Here, we characterize the activity and structure
of EF-Tu phosphorylated at T382 (pEF-TuT382), as well as mutants
mimicking other in vivo prevalent phosphorylation states of EF-Tu.
We show that modifications affecting the b-hairpin conformation of
the switch I region of EF-Tu (that precludes the interaction of EF-Tu
with aa-tRNAs) shift the conformational equilibrium of EF-Tu to the
open state. This uncouples EF-Tu from nucleotide exchange–induced1 of 14
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 RESULTS
Doc phosphorylates EF-Tu at T382
We recently showed that the toxin Doc from the toxin-antitoxin
module doc/phd hijacks the natural posttranslationalmodification cycle
of EF-Tu to target translation elongation by phosphorylation of EF-Tu
at T382 (21). In E. coli, this results in a strong protein synthesis inhibi-
tion and cell growth arrest (21, 23). Therefore, to study the structural
and functional effects of EF-Tu phosphorylation, we used Doc as a tool
to produce pEF-TuT382 in vitro. Mass spectrometry and Western
blotting confirmed that EF-Tuwas efficiently phosphorylated using this
protocol (fig. S1, A and B).
Interaction of EF-Tu and pEF-TuT382 with nucleotides
Central to the function of EF-Tu in translation elongation is the inter-
action of its G domain with GTP and GDP (17). We used isothermal
titration calorimetry (ITC) to characterize the effect of phosphorylation
on the interaction of EF-Tu with di- and triphosphate guanine nucleo-
tides [GDP and the nonhydrolyzable GTP analogs guanosine-5′-
(g-thio)-triphosphate (GTPgS) and 5′-guanylyl imidodiphosphate
(GDPNP)]. At 20°C, the observed affinity of EF-Tu for GDP was 4.5 nM,
whereas for GTPgS, it was 81 nM (Fig. 1A; fig. S2, A to H; and table S1).
These results are consistent with the affinities measured with GDPNP
(fig. S2, A to D, and table S1) and are in the range of earlier observations
that show a preference of nucleotide-free EF-Tu forGDP (24) overGTP.
The observed affinity of pEF-TuT382 for GDP was 5.7 nM, which is
on the sameorder ofmagnitude as thatmeasured for thenonphosphoryl-
ated protein (Fig. 1A; fig. S2, J and K; and table S1). Phosphorylation
did not have a major effect on the affinity for GDPNP or GTPgS,
with pEF-TuT382 binding GTPgS with a Kd (dissociation constant) of
90 nM (Fig. 1A; fig. S2, M to O; and table S1). These results were con-
firmed by stopped-flow kinetics of nucleotides binding to EF-Tu and
pEF-TuT382, using the fluorescent compounds 2′/3′N-methylanthraniloyl
(MANT)–GDP and MANT-GTPgS. Phosphorylation at T382 did not
affect the kinetics of GDP or GTPgS binding (fig. S3, A to F, and table
S2) to either EF-Tu or pEF-TuT382.
However, the thermodynamic binding profiles suggest that phos-
phorylationmay have an impact on the structure and overall conforma-
tional landscape of the protein. In the nonmodified EF-Tu, theTalavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018thermodynamic parameters of binding to GTPgS compared to GDP
are quite contrasting (table S1). Binding to GTPgS is less enthalpically
driven (DH) and is accompanied by amore severe entropic (DS) penalty
and larger change in heat capacity (DcP). In addition, binding to GTPgS
involves more residues in the contact interface as estimated from the
measured DH and DcP values (Fig. 1A, fig. S2P, and table S1). All these
observations are consistent with structural observations, indicating that
EF-Tu undergoes a large conformational rearrangement upon binding
GTPgS. These changes involve burying hydrophobic residues and do-
main movements (around 980 Å2 of the surface become buried upon
EF-Tu binding to triphosphate nucleotides) that lead to a closed and
more compacted state compared to the GDP-bound open state, in which
the three domains are more loosely arranged.
Notably, the thermodynamic binding pattern of GTPgS is signifi-
cantly changed upon phosphorylation. The interaction between pEF-
TuT382 and GTPgS is more enthalpically driven; consequently, the
binding entropic penalty is less severe and involves a lower DcP (Fig.
1A and table S1). Thus, this binding pattern resembles more closely
the interaction of EF-Tu with GDP, with fewer residues contributing
to the binding interface than in the case of the nonphosphorylated pro-
tein (Fig. 1A and table S1). By contrast, the binding parameters for the
interaction of pEF-TuT382 with GDP remain largely unchanged com-
pared to that of EF-Tu with GDP. Together, ITC and stopped-flow
experiments suggest different modes of binding of GTPgS to phos-
phorylated and nonphosphorylated EF-Tu (Fig. 1A and table S1).
Phosphorylation of EF-Tu impairs ternary
complex formation
Next, we examined the effects of phosphorylation of EF-Tu at T382 on
its interaction with elongation factor EF-Ts. EF-Ts catalyzes GDP to
GTP exchange on EF-Tu (crucial for the formation of the ternary com-
plex EF-Tu–GTP–aa-tRNA). EF-Ts has high affinity for EF-Tu in the
subnanomolar range as measured by spectroscopic methods (24). We
confirmed by ITC that EF-Tu binds EF-Ts with an affinity of 1.2 nM
(Fig. 1B, fig. S2Q, and table S1). After phosphorylation, pEF-TuT382 also
bound EF-Ts with subnanomolar affinity (0.81 nM). Thus, the interac-
tion of EF-Tu with EF-Ts seems largely unaffected by phosphorylation
at Thr382. This is not surprising given that the site of phosphorylation at
the second b-barrel domain (T382) is not involved in the EF-Ts–EF-Tu
interface (Fig. 1C and figs. S2R and 4A) (25).
After guanine nucleotide exchange by EF-Ts, the EF-Tu–GTP
complex attains the proper conformation suitable for recognizing andFig. 1. Thermodynamics of the interaction between EF-Tu and pEF-TuT382 with nucleotides, EF-Ts and Glu-tRNA
Glu. (A) Thermodynamic fingerprint of the in-
teraction between EF-Tu and pEF-TuT382 with nucleotides. The themodynamic parameters (DG, DH, −TDS, and DcP) that describe the interaction of EF-Tu with GDP and
GTPgS are compared to those for the interaction of pEF-TuT382 with GDP and GTPgS in the bar plot. ITC titration of EF-Ts into EF-Tu (B) and pEF-TuT382 (C) at 25°C. ITC
titration of pEF-TuT382 into Glu-tRNA
Glu (D) and EF-Tu into Glu-tRNAGlu (E) at 25°C.2 of 14
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 binding aa-tRNAs to form the ternary complex (EF-Tu–GTP–aa-
tRNA) of translation elongation (16). It is in the form of these ternary
complexes that EF-Tu delivers GTP and aa-tRNA to the ribosomal A
site during translation. ITC titrations show that binding ofGlu-tRNAGlu
to pEF-TuT382 in the presence of GTPgS is strongly decreased com-
pared to nonphosphorylated EF-Tu (Fig. 1, D and E, and fig. S2,
S and T). This resembles the drop in affinity of Glu-tRNAGlu for EF-Tu
in the presence of GDP (fig. S2U). This is consistent with the decrease
of in vitro ternary complex formation with Glu-tRNAGlu in the pres-
ence ofDoc (that phosphorylates EF-Tu in situ) or GDP compared to
nonphosphorylated EF-Tu (fig. S4B). These results, together with the
aforementioned nucleotide binding experiments, suggest that phospho-
rylation does not have a direct effect on the way pEF-TuT382 interacts
with nucleotides or EF-Ts, but might have a strong effect on the con-
formation and dynamic state of the enzyme, leading to a decreased af-
finity for aa-tRNAs.
Structure of phosphorylated pEF-TuT382
EF-Tu variants from different bacteria have been crystallized in differ-
ent conformations and in complex with a myriad of partners. In these
studies, two main types of conformations are observed: a closed one as-
sociated with GTP binding and an open one associated with GDP
binding (13, 26). However, there is little information regarding the
effects of posttranslationalmodifications on the structure andmolecularTalavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018mechanism of the protein. The structure of the pEF-TuT382–GDP
complex determined at 2.8 Å shows an open conformation similar to
that observed for EF-Tu in the GDP-bound state (Fig. 2, A to C, and
table S3). The binding of GDP seems unaffected by the phosphorylation
of T382 (Fig. 2, A andB), suggesting that long-range effects do not affect
the GDP binding site on the G domain. The nucleotide adopts the same
conformation observed in the crystal structure of the nonphosphoryl-
ated EF-Tu–GDP complex (26). The major structural difference is a 5°
rotation of the b-barrel I domain relative to the G domain and b-barrel
II domain as well as a local perturbation at the N-terminal side of the
switch II region of the G domain (Fig. 2D and fig. S5A). In addition,
b-barrel II is slightly closer to the G domain in the phosphorylated pro-
tein, with R59 from the switch I region directly contacting the
phosphate group of pT382 (Fig. 2C).
To assess the effects of phosphorylation on the closed state of EF-Tu
(the state compatible with aa-tRNAbinding), we determined the crystal
structure of the pEF-TuT382–GTP complex at 2.8 Å resolution by
MR-SAD (phasing using molecular replacement combined with
single anomalous dispersion). The structure shows that, upon phos-
phorylation, even after GTP binding, the protein adopts an open state
similar to that observed for theGDP-bound pEF-TuT382 (Fig. 2, E toH).
Consequently, in the pEF-TuT382–GTP complex, the b-barrel II domain
is rotated ~90° around its barrel axis compared to the structure of
nonphosphorylated EF-Tu–GTP (Fig. 2H). When bound to GTP, o
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ag.org/Fig. 2. Effects of phosphorylation on the conformational state of pEF-TuT382. (A) X-ray structure of the pEF-TuT382–GDP complex. All three domains constituting EF-Tu
(G domain and b-barrel I and II domains) are highlighted. The switch I region in the b-hairpin conformation is colored in cyan. The 2mFo-DFc simulated-annealing omit
map (s = 1) corresponding to pT382 and GDP is shown as a blue mesh. The maps were calculated after removing pT382 and GDP from the model. (B) Close-up view of
the electron density map presented in (A). (C) Details of the interactions of pT382 with R59 from the switch I b hairpin and R377 from the b-barrel II domain. (D) Ca
representation of the phosphorylated (in cyan) and nonphosphorylated (in ocher) forms of EF-Tu bound to GDP. The two structures have been superimposed by
aligning the G domain. (E) X-ray structure of the pEF-TuT382–GTP complex. All three domains constituting EF-Tu (G domain and b-barrel I and II domains) are shown
as in (A). The disordered switch I region is highlighted. The 2mFo-DFc simulated-annealing omit map (s = 1) corresponding to pT382 and GTP is shown as a blue mesh.
The maps were calculated after removing pT382 and GTP from the model. (F) Close-up view of the electron density map presented in (A) for GTP and pT382 (G). The
lack of contacts between pT382 and the switch I region due to local disordered is also highlighted. (H) Ca representation of the phosphorylated (in cyan) and nonphos-
phorylated (in ocher) forms of EF-Tu bound to GTP. The two structures have been superimposed aligning the G domain.3 of 14
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 the switch I region of pEF-TuT382 is largely disordered (Fig. 2, E and G),
specially the residues comprising the b hairpin. In the structure of the
EF-Tu–GDP complex, this region involves several residues (including
F46, I49, and D50) that make contacts and stabilized GDP in the open
form. Moreover, in the EF-Tu–GTP complex, this region is directly
involved in accommodating the g-phosphate ofGTP.The lack of electron
density in the pEF-TuT382–GTP structure suggests that the presence of
the extra negative charge perturbs the local secondary structure (Fig. 2,
E and H). This is likely due to the combined effect of the additional
phosphate groupon thenucleotide and thenegative charge onpT382 that
precludes the phosphorylated protein from collapsing into a more
compact structure. It also suggests that anchoring the switch I b hairpin
to the phosphorylated T382 (as observed in the pEF-TuT382–GDP
complex) is not the only requisite for trapping the protein in an open
state. In addition, because theGTPbinding site is altered in the open con-
formation, the g-phosphate of GTP is not properly aligned in the active
site and flips out toward the bulk solvent. This conformation is somewhat
reminiscent of the intermediate GTP-bound states observed in the open
EF-Tu during the nucleotide exchange reaction catalyzed by EF-Ts
(fig. S5B). These intermediate states can accommodate triphosphate
nucleotides in the presence or absence of Mg2+ without triggering
the transition to a compact form (27). This dynamic behavior of the
GTP-boundG domain has also been described for the equilibrium be-
tween active and inactive forms of GTP-ras_p21 complexes (28).
We used small-angle x-ray scattering (SAXS) to probe the confor-
mational state of EF-Tu and pEF-TuT382 in solution, in the presence of
di- and triphosphate nucleotides. The scattering data of EF-Tu bound to
GDP confirmed that the protein adopts the typical open conformation
observed in the crystal structure (Fig. 3A) (26). The solution scattering
profile of pEF-TuT382 bound to GDP also agrees with the open confor-
mational state observed in the crystal structure (Figs. 2A and 3B). As
expected, in the presence of GDPNP or GTPgS, nonphosphorylatedTalavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018EF-Tu is in the more compact, closed state (Fig. 3C and table S4)
(14). As observed in the crystal structure (Fig. 2E) of pEF-TuT382 in
complex with GTP, in solution the complexes of pEF-TuT382 with
GTPgS or GDPNP show maximum dimensions (Dmax) that are ~10 Å
bigger than the nonphosphorylated protein bound to GTPgS (Fig. 3, C
and D, and table S4).
These results, together with the different crystal structures of pEF-
TuT382, suggest that pEF-TuT382 predominantly populates predominantly
an open state independent of the bound nucleotide.When looking in de-
tail at the structure of the EF-Tu–GTPgS complex, T382 is buried in a
hydrophobic interface created by the switch II region of the G domain
and b-barrel II domain in the closed EF-Tu conformation (fig. S5, C
and D). When we superimpose b-barrel II from pEF-TuT382 onto the
structure of the nonphosphorylated EF-Tu–GTPgS complex, it is clear
that phosphorylation of T382 is incompatible with this closed conforma-
tion. Not only would the presence of a phosphate group drastically dis-
turb the conformation of the switch II region (fig. S5D), but also the
energetic penalty of burying the phosphate in a hydrophobic cavitywould
simply preclude the existence of such a conformation.
Phosphorylation at T382 impairs EF-Tu dynamics
On the basis of the aforementioned observations, we hypothesized that
at the structural level, phosphorylation interferes with the dynamic
coupling between nucleotide binding and the conformational switch,
intrinsic to EF-Tu. To provide insights into the conformational dy-
namics of EF-Tu, we used the single-pair Förster resonance energy
transfer (spFRET) method.
spFRET probes 1- to 10-nm distances between fluorescent donor
and acceptor attached to specific residues of a single freely diffusing pro-
tein. Distance fluctuations, equilibrium distribution, and kinetics of
conformer interconversion on the 0- to 10-ms time scale, arising from
conformational dynamics, can be quantified with spFRET. On the basis o
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org/Fig. 3. SAXS-based structural models of EF-Tu and pEF-TuT382 in complex with GDP and GTPgS. Solution structures of pEF-TuT382–GDP (A), pEF-TuT382–GTPgS (B), EF-Tu–
GDP (C), and EF-Tu–GTPgS (D). Themodel of E. coliEF-Tu–GTPgS in the closed statewas reconstructed on the basis of the coordinate 1EXM (66) and is in verygood agreementwith
the experimental SAXS data. The atomic model of the different complexes is superimposed on the ab initio calculated SAXS envelope shown as a blue meshed surface. In each
case, the particle dimensions and experimental (in black) and model-derived (in red) SAXS curves are shown below each model. The calculated ab initio envelopes and exper-
imental SAXS data of the complexes of pEF-TuT382 with GDP, GTPgS, and GDPNP (table S4) are in good agreement with the crystal structures and strongly indicate that, upon
phosphorylation, pEF-TuT382 is in an open conformation independent of the bound nucleotide. a.u., arbitrary units.4 of 14
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 of accessible volume calculations, we selected possible solvent-exposed
residues on EF-Tu for covalently attaching dyes. For residues C82 in the
G domain and S222 in the b-barrel domain, the FRET-averaged in-
terdye distance 〈RDA〉E is predicted to be ~62 Å in the GDP state and
~41 Å in theGTP state (Fig. 4, A and B). These positions are sufficiently
far from the phosphorylation site (Fig. 4, A to B), and mutations at
S222C have negligible effects on nucleotide binding and the confor-
mational cycle of EF-Tu (29, 30). Direct titrations of nucleotides to
EF-TuS222C showed that the mutant retains wild type–like affinity.
Thus, we coupled the maleimide derivatives of ATTO 488 and Alexa
Fluor 647 dyes to the thiol group of C82 and S222C (see fig. 6, A to G,
for additional details on the labeling and analysis process) for the
spFRET measurements.
The efficiency of the FRET process (E) and the average time the do-
nor probe spent in the excited state (tD(A))were calculated for individual
EF-Tumolecules (~100 pM) in the presence of 1mMGDP (Fig. 4C and
fig. S7A) or 1 mM GDPNP (Fig. 4D and fig. S7B). To quantitatively
describe the conformational dynamics underlying the FREThistograms
using photon distribution analysis (PDA), we set up amethodology that
allowed global analysis of theGDP andGDPNPdata sets (fig. S6B). The
methodology involved the improved fitting robustness by globally
linking fitting parameters, thereby reducing their number (fig. S6, C
and D) and performing a detailed in silico analysis to accurately obtain
the range of the rate constants (fig. S6, E to G). From this analysis, the
interaction of EF-Tu with GDP could be adequately described using a
model that assumed two invariable states with EF-Tu (on the <10-ms
observation time scale) in a predominantly open conformation (Fig. 4E
and fig. S7A). By contrast, in the case of interaction with GDPNP, we
observed a nonlinear relation between E and tD(A) (Fig. 4D and fig.
S7B), suggesting the presence of conformational dynamics on a 1- to
10-ms time scale. Accordingly, a model that assumed dynamically in-
terconverting states described the interaction with GDPNP in a better
way (Fig. 4F). The results show that GDPNP drastically increased the
rate at which the protein opened and closed (Fig. 4, G andH, and tables
S5 to S7), and that the open/closed equilibrium in EF-Tu-GDPNP is
tipped toward the closed state (Fig. 4, F and I). These results are in agree-
ment with crystallographic and SAXS data of EF-Tu with GDP and
GDPNP and validate our system tomonitor the EF-Tu conformational
cycle (14, 26).
We next performed a similar analysis of the interaction of phos-
phorylated EF-Tu with nucleotides (Fig. 4, J to N). In the presence of
GDP, pEF-TuT382 was observed predominantly in the open conforma-
tion, as was the nonphosphorylated protein (Fig. 4N and fig. S7C), and
exhibited no conformational dynamics on the FRET time scale (Fig. 4,
G, H, and L). In the presence of GDPNP, pEF-TuT382 was also observed
predominantly in the open (Fig. 4N and fig. S7D) and rather static con-
formation, switching only very slowly back and forth between open and
closed states (Fig. 4, G, H, andM). These results indicate that phospho-
rylation decelerates conformational dynamics and tips the conforma-
tional equilibrium of pEF-TuT382 in favor of the open conformation,
thus decoupling nucleotide binding from the conformational cycle that
EF-Tu requires for its proper function during translation elongation
(that is, nucleotides no longer affect the conformation of the protein).
T382E mimics the effect of phosphorylation on
EF-Tu dynamics
The structure of pEF-TuT382 suggests that the introduction of a negative
charge in the loop containing T382 might prevent the compact state of
EF-Tu associated with binding to GTP, thus trapping the protein in anTalavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018open conformation. To challenge this hypothesis, we introduced the
T382E mutation, a potential mimic of a phosphorylated Thr residue,
and used spFRET to monitor the EF-TuT382E nucleotide-dependent
conformational cycle. In the presence of GDP or GDPNP, EF-TuT382E
remained preferentially in the open state similarly to pEF-TuT382 (Fig.
4O and fig. S8, A and B). Detailed kinetic analyses additionally revealed
that the opening/closing equilibrium was significantly decelerated, al-
though it was still faster than the phosphorylated protein (Fig. 4, G
and H, and fig. S9, A and B).
Thus, the presence of a negative charge in this position is sufficient to
mimic the effects of phosphorylation in EF-Tu. The structure of the EF-
TuT382E–GDP complex is almost identical to that of pEF-TuT382 bound
to GDP or GTP (fig. S10A and Fig. 2, A and E). E382 that replaces the
pT382 is involved in electrostatic interactions with the switch I region
via R59, as seen in the case of pEF-TuT382. All these results strongly sug-
gest that EF-TuT382E is a bona fide structural and functional mimic of
pEF-TuT382.
T61 is an allosteric hotspot involved in EF-Tu
conformational dynamics
The conformation of the switch I region is intricately related with the
open/closed state of G proteins and, in the case of EF-Tu, with the over-
all structural arrangement. On the basis of our structural observations
on the link between the switch I region and phosphorylation of T382 at
the b-barrel II domain, it is tempting to predict that posttranslational
changes in EF-Tu, perturbing the switch I region b-hairpin conforma-
tion, would be an effective way of trapping the protein in an open con-
formational state.
T61 from the switch I region is another major phosphorylation site
observed across bacterial proteomes. Therefore, we hypothesized that
during translational arrest caused by T61 phosphorylation (8), the
underlying molecular mechanism would again be decoupling of nucle-
otide binding from the EF-Tu conformational dynamics and trapping
EF-Tu in an open conformational state.
To test this, we produced the T61E mutant to mimic E. coli EF-Tu
phosphorylated at T61 (EF-TuT61E). The structure of EF-TuT61E bound
to GDP was very similar to that of EF-TuT382E and pEF-TuT382 bound
toGDP orGTP (fig. S10, A and B, and Fig. 2, A and E). E61 is located at
the C-terminal b strand of the hairpin of the switch I region and inter-
acts with K56 from the first b strand of this hairpin and thus stabilizes
the overall b-hairpin conformation of the switch I region (fig. S10B).We
also measured the influence of the T61E mutation on the nucleotide
binding–dependent conformational switch using spFRET. In the pres-
ence of GDP, EF-TuT61E stays in the open form observed in the crystal
structure (Fig. 4P and figs. 8C and 9C). As expected, in the presence of
GDPNP, EF-TuT61E also slightly favored the open conformation (Fig.
4P and figs. 8D and 9D). In addition, the phosphomimic EF-TuT61E was
significantly less dynamic than the wild-type protein (Fig. 4, G and H).
Implications of the conformational trap on the
structure-function interplay of EF-Tu
EF-Tu can be extensivelymodified posttranslationally (31). Thesemod-
ifications have a strong impact on bacterial metabolism and play an im-
portant role in shaping the phenotype of bacterial populations. Several
of these modifications occur in response to nutrient starvation, station-
ary phase growth, or dormancy. From the 100 or more phosphopep-
tides observed in the E. coli and B. subtilis phosphoproteome, 10 are
derived from EF-Tu (2, 18, 19). The phosphorylation sites are spread
in all three domains of EF-Tu (table S8).5 of 14
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 Fig. 4. EF-Tu conformationaldynamics in thepresenceof nucleotidesassessedby spFRET. (A andB) Structuralmodels of EF-Tu in the (A) open and (B) closed conformation.
Dye attachment sites are Cys82 and Cys222. (C and D) Two-dimensional (2D) histograms of the FRET efficiency E versus the donor fluorescence lifetime tD(A) with 1D projections
obtained after spFRET analysis of (C) EF-Tu–GDP and (D) EF-Tu–GDPNP. A 15% offset in z was used to reduce noise in the 2D histograms. Overlayed is (solid line) the theoretical
relation between E and tD(A) in the absence of 1- to 10-ms FRET dynamics calculated using a tD estimated from the D-only population, an R0 = 53 Å, and Gaussian distributed fast
dye fluctuations over 6 Å. (E and F) Static versus dynamic PDA analysis of EF-Tu in the presence of (E) GDP and (F) GDPNP. The insets illustrate the substrates used for dynamic PDA
analysis [that is, the relative abundance ofmolecules that coincidently were only in the open (red) or closed (blue) state, andmolecules that interconverted from one state to the
other during diffusion through the probe volume (green)]. The (relative) area under the green substrate is directly proportional to the chance of observing a molecule that
interconverted while diffusing through the probe volume; the larger this area, the more robustly can kinetic rate constants be derived from the data by dynamic PDA.
(G) Bar chart of the kopening and kclosing rate constants. The postfitting 95% relative confidence intervals were very low (<5%) for all parameters, except the k values (smaller
than 20% for k > 0.25 s−1). The resulting rate constants are presented as the average ± SD of at least three independentmeasurements originating from at least two protein
purification batches. The significances also apply to the data in (H). (H) Bar chart of the corresponding closed and open state dwell times. Dwell times > 5 ms were not
quantified because of the high uncertainty of the corresponding interconversion rate constants (suggesting much slower conformational dynamics). For wild-type EF-Tu,
the dwell time in the closed state was only slightly lower (P < 0.05) than that in the open state. GDPNP thus accelerates the rate of opening/closingwith respect to GDP, and
this frequent sampling of the closed state likely allows the protein to crystallize in this conformation. (I) Equilibrium distance distribution for different variants of EF-Tu,
calculated from the kopening and kclosing rate constants. (J and K) 2D histograms of the FRET efficiency E versus the donor fluorescence lifetime tD(A) with 1D projections
obtained after spFRET analysis of (J) pEF-TuT382–GDP and (K) EF-Tu–GDPNP. (L andM) Static versus dynamic PDA analysis [as in (E)] of (L) pEF-TuT382 with GDP or (M) GDPNP.
(N to Q) Equilibrium distance distribution for (N) pEF-TuT382 and the different EF-Tu mutants (O) EF-TuT382E, (P) EF-TuT61E, and EF-TuR59D (Q).Talavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018 6 of 14
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 When we mapped these sites on the surface of EF-Tu in the closed
conformation (Fig. 5A), the majority of the sites were fully buried, only
partially exposed (less than 10%), or involved in aa-tRNA interactions,
with only one site (S158) fully exposed (Fig. 5B). This implies that dur-
ing normal translation, the closed-form EF-Tu would be rather
protected from hyperphosphorylation. This is in stark contrast with
the open conformation where at least five sites become exposed as a
result of the nucleotide exchange (Fig. 5C). Hyperphosphorylation of
EF-Tu has been described in several metabolic states. Considering that
reversible protein phosphorylation is a true signal transduction device
and that some of these sites are highly conserved (fig. S11), it is tempting
to hypothesize that differential phosphorylation can set a threshold for a
particular differentiated phenotypic state. Further experimental evi-
dence will be needed to validate such a hypothesis.DISCUSSION
Translation factors have been observed in the phosphoproteomes of
diverse organisms, suggesting that they are subject to regulation by
phosphorylation (7, 18, 19, 32, 33). EF-Tu is extensively modified post-
translationally depending on the cellular state and growth conditions (31).Talavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018Several of these modifications are directly involved in bacterial survival
strategies and stress tolerance. In E. coli, the toxin Doc stalls translation
and arrests growth by phosphorylating EF-Tu at T382 (21, 23). In
Salmonella, Doc is likely a key player in the differentiation of persister
cells (34). Hyperphosphorylation of EF-Tu in E. coli, Mycobacterium
tuberculosis, and Mycobacterium smegmatis reduces protein synthesis
and cell growth (20). During nutrient starvation, B. subtilis forms a
metabolically quiescent, highly resistant spore (8). This process is
triggered by the phosphorylation of EF-Tu by YabT (at T65 and
T385, the equivalents of E. coli T61 and T382), resulting in the accu-
mulation of pEF-Tu on ribosomes and the consequent inhibition of
translation (8).
Currently, there are two contrasting models that try to explain how
phosphorylation inhibits the function of EF-Tu. The first model states
that phosphorylation impairs ternary complex formation, which, in
turn, precludes the interaction with the ribosome (22). This model
is based on the analysis of the interaction of pEF-Tu with kirromycin
in the context ofGDP,GTP, and aa-tRNA. The authors predicted that,
upon phosphorylation, the conformational landscape of the protein
may be affected and that pEF-Tu adopts a new conformation different
from that of GDP–GTP–aa-tRNA complexes (22). They argue that
this new conformation could accelerate the kinetics of detachment of
pEF-Tu from the ribosome compared to the nonphosphorylated pro-
tein. The second model states that the pEF-Tu–GTP complex stays
bound to the ribosome because the GTPase activity is impaired (8).
Ribosome pull-down assays in B. subtilis showed that pEF-Tu is
enriched in the pellets containing 70S ribosomes, and the authors con-
cluded that stabilization of the pEF-Tu–GTP–ribosome complex is
what stalls translation (8). Both models put the effect of EF-Tu phos-
phorylation at a different step in translation and therefore seemmu-
tually exclusive.
Our data show that the inactivation of EF-Tu upon phosphorylation
is based on the decoupling of nucleotide binding from the conforma-
tional cycle of the protein (Fig. 6). Phosphorylation traps EF-Tu in a
conformational state that is closely related—if not identical—to the
open form associated with GDP binding. In this form, GTP can be
bound, but not hydrolyzed, and impaired dynamics also prevents
binding of aa-tRNA and transferring to the translating ribosome. In this
conformation, the affinity for ribosomes is likely to be weak as well and
is difficult to reconcile with a stabilized ribosome–pEF-Tu–GTP
complex. We have observed that phosphorylation also significantly de-
creases the solubility of EF-Tu, leading to aggregation in vitro. This
might explain why, upon phosphorylation, pEF-Tu is found in pellets
together with 70S ribosomes.
Phosphorylation of E. coli EF-Tu at T382 traps the protein in its in-
active open conformation independent of the nucleotide bound to the
G domain. The electronegative charge of the phosphate group of pT382
would strain the closed state of EF-Tu significantly, suggesting that the
presence of a phosphate is incompatible with the closed active state.
Using the phosphomimetic T61E mutant, we showed that the effect
of phosphorylation is again to trap pEF-TuT61 in an open inactive state
or at least shift the dynamic equilibrium toward a dominant non-
functional state. In this case, the phosphate group of pT61 interacts with
K56, thereby stabilizing the b-hairpin conformation of switch I. As is the
case of pT382, phosphorylation of T61 would lead to major clashes in
the closed conformation of pEF-TuT61, indicating that it is incom-
patible with the closed active state. EF-Tu is methylated and subse-
quently dimethylated at K56 upon entering the stationary phase in
response to nutrient starvation (4). This perturbation of the switch IFig. 5. EF-Tu phosphorylation is intricately related with the protein confor-
mational cycle. (A) In the closed state (EF-Tu–GTP complex), all the phosphoryl-
ation sites experimentally validated for EF-Tu are either buried or poorly
accessible to the solvent. (B) In the closed conformation when bound to aa-tRNA
(which is likely the more abundant state of the EF-Tu–GTP complex given the
high affinity for aa-tRNA), only two phosphorylation sites are not involved in in-
teractions with the aa-tRNA, and they have very low solvent accessibility. (C) In
the open state, four sites become accessible by >25% and three others are par-
tially accessible. This suggests that a modification trapping EF-Tu in an open state
would increase the likelihood of additional modifications.7 of 14
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 K56 by methylation is suggested to attenuate GTP hydrolysis and
enhance translational accuracy (3).
Different phosphorylation sites with their distinct and overlapping
functions and mechanisms not only allow fast stress responses but also
seamlessly function as versatile epigenetic response systems, important
for the adaptationof anorganism to specific environments. In Streptomyces,
ribosomal proteins are phosphorylated to attenuate translational activ-
ity when other ribosomal proteins are of low abundance, whereas in
Bacillus phosphorylation is one of several dormancy switches (8, 35).
EF-Tu is highly conserved in bacteria, including the key phosphoryl-
ation sites T61 and T382 (8, 18, 19). Therefore, decoupling nucleotide
binding from EF-Tu dynamics and the entrapment of pEF-Tu in a
unique conformation that disrupts the translation cycle (Fig. 6) are like-
ly general translation inhibition strategies among bacteria. After the ini-
tial phosphorylation event, which is sufficient to inactivate EF-Tu (with
the protein trapped in the open form), subsequent phosphorylation
might be facilitated, leading to the hyperphosphorylation of EF-Tu ob-
served in bacterial cells under different conditions (5, 18–20). This mul-
tisite phosphorylation could set a functional barrier preventing recoil
from dormancy, cell cycle transitions, and other differentiation states
observed in bacterial populations expressing phenotypic heterogeneity.
The functional significance of the decoupling of nucleotide binding
from the EF-Tu conformational dynamic cycle may be relevant even in
eukaryotes. The eukaryotic translation elongation factor eEF-1A2, an
EF-Tu homolog, is AMPylated at a position structurally equivalent to
E. coli T382 (36). In this case, a eukaryotic FIC enzyme (structural
homolog of the bacterial kinaseDoc butwith adenylyltransferase activity)
catalyzes the AMPylation reaction. One can easily imagine that the intro-
duction of an AMP group at T382 would preclude the closed conforma-
tion, as does a phosphate group. This modification leads to translation
inhibition and has amajor effect in the survival ofCaenorhabditis elegans
upon Pseudomonas infection (36).
Overall, our results show that posttranslational modifications
affecting the stability of the switch I region of EF-Tu are directly in-
volved in tuning protein dynamics and are efficient allosteric switches.
Moreover, phosphorylation is a very efficient conformational trap that
keeps EF-Tu in an inactive open conformation, incompatible with
translation. This conformational trap may be the linchpin behind fur-
ther hyperphosphorylation observed during dormancy.Talavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018MATERIALS AND METHODS
Protein expression and purification
Wild-type Doc was purified as described previously (37–40). Cells
transformed with a plasmid containing the phd/doc operon under a
T7 promoter were grown in LB medium [supplemented with ampi-
cillin (100 mg/ml)] at 310 K until the A600 was between 0.6 and 0.8.
Expression of the genes was induced by adding 1mM isopropyl-b-D-
thiogalactopyranoside (IPTG). The cells were harvested by centrifu-
gation 2 hours after induction and subsequently resuspended in 20mM
tris-HCl (pH 8.0), 1 mMEDTA, and a protease inhibitor cocktail. The
cells were lysed with a cell disruptor at 277 K, and cell debris was re-
moved by centrifugation. The cleared extract was loaded onto a Ni–
nitrilotriacetic acid affinity column (connected to an ÄKTAexplorer
FPLC system, GE Healthcare) pre-equilibrated in 20 mM tris-HCl
(pH 8.0) and washedwith the same buffer to remove nonbinding con-
taminants. To separate wild-type Doc from the antitoxin Phd, the
procedure extensively described in previous studies (37–40) was
followed.
His-tagged EF-Tu and the phosphomimetic mutants were purified
on the basis of the protocol described by Castro-Roa et al. (21). Cells
were grown in LB media supplemented with ampicillin (100 mg/ml)
at 37°C until anA600 = 0.4 was reached. Protein expression was induced
with IPTG (0.25 mM) at 30°C for 4 hours. After induction, cells were
pelleted and washed twice with phosphorylation buffer (PB) containing
10mMHepes (pH 7.5), 60mMNH4Cl, 10mMMg
2+ acetate, and 2mM
tris(2-carboxyethyl)phosphine (TCEP). Pellets were resuspended in
PB and EDTA-free protease inhibitor cocktail (Roche) and incubated
on ice with lysozyme (0.1 mg/ml) for 30 min. Cells were disrupted by
sonication in stainless steel tubes in an ice-water bath for 15 min,
followed by two clearing centrifugation steps at 15,000 rpm in a JA-
25.50 Beckman rotor. The supernatants were then applied onto a 5-ml
HisTrap column (GE Healthcare) connected to an ÄKTAexplorer
FPLC system (GEHealthcare). Elutionwas performedwith a linear gra-
dient of imidazole (from 10 to 200 mM) in 20 mM Hepes (pH 7.4)
and 600 mM NaCl. Peak fractions were pooled and analyzed by SDS–
polyacrylamide gel electrophoresis. Fractions containing EF-Tu were
further purified by size exclusion chromatography (SEC) in PB. EF-Ts
and all the EF-Tu mutants described in this work were produced and
purified in the same way.Fig. 6. Regulation of the EF-Tu function in translation by phosphorylation. During translation, EF-Tu is observed in two predominant conformational states coupled to the
nucleotide bound at a given moment. When bound to GTP, EF-Tu is in a closed state compatible with aa-tRNA binding (all three domains, shown in different shades of blue, are
tightly packed).Whenbound toGDP, EF-Tu is in an open statewith significantlyweaker affinity for aa-tRNAbinding (the three domains aremore loosely arranged). This open form
cannot usher aa-tRNAs to the ribosome for the elongation of protein synthesis. Phosphorylation (represented by a red dot) of EF-Tu traps the protein in its inactive open con-
formation independent of the nucleotide bound to the G domain. As shown in Fig. 1 (D and E), this decoupling of the conformational cycle fromnucleotide binding precludes aa-
tRNAbinding and strongly inhibits translation. As in the case of the openGDP-bound form, phosphorylated EF-Tu is incompatiblewith aa-tRNAbinding and cannot forma ternary
complex to deliver aa-tRNAs to the ribosome (21). In this stable open state, subsequent phosphorylation might be facilitated, establishing a functional barrier preventing recoil
from dormancy and other differentiation states.8 of 14
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 For the in vitro phosphorylation of EF-Tu, 1 mg of protein was in-
cubated for 20min at 37°C in the presence of 250 nMDoc and 250 mM
adenosine triphosphate (ATP). The reaction buffer consisted of 50mM
Hepes (pH 7.5), 2 mMMgCl2, 40 mMNH4Cl, and 2 mM TCEP. After
phosphorylation, pEF-TuT382 was further purified by SEC.
Native mass spectrometry
EF-Tu and pEF-TuT382 samples were prepared at 10 mM protein con-
centration in 100mMammoniumacetate buffer (pH6.9). Both samples
were introduced into the vacuum of themass spectrometer using nano-
electrospray ionization with in-house–prepared gold-coated boro-
silicate glass capillaries with a voltage of approximately +1.4 kV.
Spectra were recorded on a SYNAPT G2 HDMS Q-TOF (Waters) in-
strument. Critical voltages throughout the instrument were 50, 1, 25,
45, and 0.5 V for the sampling cone, extraction cone, trap collision
voltage, trap dc bias, and transfer collision energy, respectively. Pres-
sure throughout the instrument was 2.87 mbar for the source, 3.22 ×
10−2 mbar for the trap collision cell, and 3.23 × 10−2 for the transfer
collision cell. Mass spectra were externally calibrated using CsI, and
themass spectrometry data were analyzed using theMassLynx software
version 4.1 (Waters).
Isothermal titration calorimetry
ITC titrations were carried out on an Affinity ITC (TA Instruments).
Before the measurement, nucleotide-free EF-Tu, pEF-TuT382, and EF-Ts
were dialyzed to 50 mMHepes (pH 7.4), 40 mMNH4Cl, 2 mMMgCl2,
and 1 mM TCEP. In each case, nucleotides were prepared with buffer
from the last step of protein dialysis. The samples were filtered and de-
gassed for 10 min before being examined in the calorimeter, and the
titrations were performed at temperatures ranging from 10° to 35°C.
All the experiments consisted of injection of constant volumes of 2 ml
of titrant into the cell (200 ml) with a stirring rate of 75 rpm. Nominal
sample concentrations were between 5 and 20 mM in the cell and 100
and 500 mM in the syringe. Actual sample concentrations were
determined after dialysis or buffer exchange bymeasurement of their ab-
sorption at 280 nm. All data were analyzed using the MicroCal Origin
ITC 7.0 and NanoAnalyze software packages. Binding affinities are re-
ported in table S1.
Analysis of the thermodynamic data
We performed ITC titrations at different temperatures to obtain the
thermodynamic parameters describing the structural-energetic inter-
play of EF-Tu and pEF-TuT382 with different ligands. The Gibbs-
Helmholtz and Kirchhoff relations allow the calculation of the affinity
of the interaction and the change in heat capacity upon binding (Dcp,
assumed to be constant across the range of experimental tempera-
tures) as follows
dðDG=TÞ
dT
¼ DH
T2
ð1Þ
dDH
dT
¼ Dcp ð2Þ
From this analysis
DG ¼ DH  TDS ð3ÞTalavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018DG ¼ RT lnð1=KdÞ ð4Þ
DHðTÞ ¼ DHrðTrÞ þ DcpðT  TrÞ ð5Þ
Dcp can be estimated from the slope of the plot of DH(Ti) versus Ti .
In addition, Dcp and DHr(Tr) are empirically related to the polar
(DASAp) and nonpolar (DASAn) solvent accessible surface area
(ASA) of all participants, where DHr is the enthalpy change at a
reference temperature Tr
DHrðTrÞ ¼ a⋅DASAp þ b⋅DASAn ð6Þ
Dcp ¼ c⋅DASAp þ d⋅DASAn ð7Þ
a=31.4calmol−1Å−2,b=−8.44calmol−1Å−2,c=−0.26calmol−1K−1Å−2,
and d = 0.45 cal mol−1 K−1 Å−2 are empirical coefficients determined for
the reference temperature Tr = 60°C, taken fromMurphy and Freire (41)
and Xie and Freire (42). The values for the buried area were converted
into the amount of amino acids that were removed from the surface
using the average ASA for apolar (34 Å2) and polar (56 Å2) amino acids
(43). All the experimentally determined and calculated thermodynamic
parameters are reported in table S1.
Stopped-flow kinetics
Nucleotide binding kinetics were determined by fluorescence
stopped-flow (SX18.MV; Applied Photophysics). All measurements
were performed at 20°C in 50 mM tris (pH 7.5), 2 mMMgCl2, 40 mM
NH4Cl, and 2 mM b-mercaptoethanol. EF-Tu or pEF-TuT382 at a
concentration of 1 mMwas rapidly mixed with a concentration range
(5 to 25 mM) of MANT-labeled nucleotides (MANT-GDP and
MANT-GTPgS; Jena Bioscience). MANT-labeled nucleotides were
excited indirectly at 280 nm using resonance energy transfer (FRET)
between tryptophan and the MANT-labeled nucleotide, and the
change in fluorescence was monitored through a 405-nm cutoff filter.
For each nucleotide concentration, the data of at least five time traces
were averaged and fitted to a single exponential function, yielding the
observed rate constant kobs. The association rate constant kon was ob-
tained from the slope of the linear fit plotting the kobs versus the nu-
cleotide concentration. The dissociation rate constant koff was obtained
by mixing 200 mM unlabeled GDP with a mixture of 0.4 mM protein
and 1.5 mM MANT-labeled nucleotide. The resulting time traces
were fitted to a single exponential function. All measurements were
performed as three independent repeats, and kon and koff values are
given as means ± SD. The Kd values were calculated from the ratio of
koff and kon.
[3H]Glu-tRNAGlu incorporation
[3H]Glu-tRNAGlu was prepared as described (44). The samples
containing EF-Tu–GTP, EF-Tu–GDP, and pEF-TuT382–GTP were
transferred to ice, and 6 ml of [3H]Glu-tRNAGlu (0.5 mM) was added
to the mix to reconstitute the elongation complexes. After incubation
at 0°C for 15 min, 3 ml of ribonuclease (RNase) A (at 0.7 mg/ml) was
added and the reaction was incubated for 3 min. To quench RNase A
activity, 5 ml of total tRNA was added followed by 40 ml of ice-cold 10%
trichloroacetic acid (TCA). The reaction was filtered through a nitro-
cellulose filter (Bio-Rad) and washed six times with 200 ml of ice-cold9 of 14
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 5% TCA. A final washing of 200 ml of 95% ethanol was performed, and
the filters were allowed to dry. The filters were then transferred to scin-
tillation vials containing 5ml of scintillation cocktail, and the amount of
[3H]Glu was determined by a scintillation counter machine.
Fluorescent labeling
Oxygen was removed from the buffer [40 mM tris (pH 7.5), 40 mM
(NH4)2SO4, 2 mM MgSO4] under vacuum and continuous stirring.
TCEP was removed from the protein solution by gel filtration (PD-10
desalting columns, GEHealthcare Europe GmbH), and the protein was
concentrated to at least 20 mM by ultrafiltration (nominal molecular
weight limit = 10 kDa, Amicon Ultra-0.5, Merck Chemicals N.V.)
at 6000g and 10°C. A sixfold molar excess of ATTO 488 maleimide
(ATTO-TEC GmbH) and ninefold molar excess of Alexa Fluor 647 C2
maleimide (Life Technologies Europe BV)weremixed. The proteinwas
added to a final concentration of at least 20 mM (preferentially 50 mM),
and the samples were incubated for 2 hours at room temperature or
overnight at 4°C. Unreacted dye was removed by gel filtration and
ultrafiltration. A typical labeling result can be found in fig. S6A. The
ATTO 488 maleimide typically had a 30 to 50% higher tendency for
labeling the protein than the Alexa Fluor 647 maleimide. This could
be due to the dye’s charge (ATTO 488, 1+; Alexa Fluor 647, 4−/1+),
size (ATTO 488, 710 Da; Alexa Fluor 647, ~1250 Da), or structure.
Between 20 and 50%of proteins typically carried two dyes after labeling.
In our experience, this percentage depended on the protein concentra-
tion before labeling, the used dye batch, the degree of reduction of the
Cys-SH moiety, and the time between protein purification and
labeling. However, because FRET experiments are carried out using
alternating FRET donor and acceptor excitation, the presence of each
dye can be independently verified per passing molecule; the resulting
FRET histograms thus present 100% of double-labeled molecules.
Buffer containing 50% (w/v) glycerol was added 1:1, and the labeled
protein sample was divided into aliquots and flash-frozen in liquidN2.
However, because freezing/thawing unpredictably caused the appear-
ance of a significant E = 0.9 to 1 FRET state, experiments were pref-
erentially carried out on the freshly labeled, nonfrozen protein.
FRET sample preparation
The labeled proteinwas diluted to 0.5 to 1 mMin buffer containing 10mM
of the nucleotide (GDP andGppNp from Jena Bioscience). Themixture
was incubated for 2 hours at 37°C and further diluted at room tempera-
ture to 50 to 100 pM protein in buffer containing 1mMnucleotide and
bovine serum albumin (BSA) (0.1 mg/ml) (Sigma-Aldrich), and 30 ml
was put on a coverslip (Nunc Lab-Tek Chambered Coverglass, Thermo
Fisher Scientific BVBA) that was first incubated with BSA (1 mg/ml)
and then washed twice with the sample solution. The background
(needed for calculating E and S parameters, and for lifetime and PDA
analysis) or scatter profile (needed for lifetime analysis) reference con-
sisted of the same sample but without the protein or nucleotide. The
small extra contribution of 1 mM nucleotide had a negligible effect.
Measurements were performed at 22° or 37°C by placing the sample
in a custom sample holder that was connected to a thermostatic water
bath. When measurements were performed directly after mixing the
protein and nucleotides, the closed/open ratio for the GDP state was
higher. We attribute this to the presence of trace amounts of GTP in
the GDP preparation. Therefore, we tested different premeasurement
incubation conditions: overnight on ice and 2 hours at 37°C. We also
tested whether measuring at 37°C instead of room temperature had an
effect on the protein conformation.Talavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018spFRET data recording
spFRET data were recorded on a homebuilt multiparameter fluorescence
detectionmicroscopewith pulsed interleaved excitation (MFD-PIE) (45).
Emission from a pulsed 483-nm laser diode (LDH-P-C-470, PicoQuant)
was cleaned up (Chroma ET485/20x, F49-482; AHF analysentechnik
AG), emission from a 635-nm laser diode (LDH-P-C-635B, PicoQuant)
was cleaned up (Chroma z635/10x, PicoQuant), and both lasers were
alternated at 26.67 MHz (PDL 828 Sepia II, PicoQuant), delayed
~18 ns with respect to each other, and combined with a 483-nm re-
flecting dichroicmirror in a single-mode optical fiber (coupler, 60FC-4-
RGBV11-47; fiber, PMC-400Si-2.6-NA012-3-APC-150-P, Schäfter +
Kirchhoff GmbH). After collimation (60FC-L-4-RGBV11-47, SuK
GmbH), the linear polarization was cleaned up (CODIXX VIS-600-
BC-W01, F22-601; AHF analysentechnik AG), and the light (100 mW
of 483-nm light and 50 mWof 635-nm light) was reflected into the back
port of the microscope (IX70, Olympus Belgium NV) and upward
[3-mm-thick full-reflectiveAgmirror, F21-005 (AHF)mounted in a total
internal reflection fluorescence filter cube for BX2/IX2, F91-960; AHF
analysentechnik AG] to the objective (UPLSAPO-60XW, Olympus).
Sample emission was transmitted through a 3-mm-thick excitation
polychroic mirror (Chroma zt470-488/640rpc, F58-PQ08; AHF anal-
ysentechnik AG), focused through a 75-mm pinhole (P75S, Thorlabs)
with an achromatic lens (AC254-200-A-ML, Thorlabs), collimated again
(AC254-50-A-ML, Thorlabs), and spectrally split (Chroma T560lpxr,
F48-559; AHF analysentechnik AG). The blue range was filtered (Chroma
ET525/50m, F47-525, AHF analysentechnik AG), and polarization was
split (PBS251, Thorlabs). The red range was also filtered (Chroma
ET705/100m, AHF analysentechnik AG), and polarization was split
(PBS252, Thorlabs). Photons were detected on four avalanche photo-
diodes (PerkinElmer or EG&G SPCM-AQR12/14), which were con-
nected to a time-correlated single-photon counting (TCSPC) device
(SPC-630, Becker & Hickl GmbH) over a router (HRT-82, Becker &
Hickl) and power supply (DSN 102, PicoQuant). Signals were stored in
12-bit first-in-first-out (FIFO) files. Microscope alignment was carried
out using fluorescence correlation spectroscopy (FCS) on freely diffusing
ATTO488-CAandATTO655-CA (ATTO-TEC) and by connecting the
detectors to a hardware correlator (ALV-5000/EPP) over a power splitter
(PSM50/51, PicoQuant) for alignment by real-time FCS. Data were
loaded in thePAMsoftware (D.C.Lamb,Ludwig-Maximilians-Universität
Munich)written inMATLAB(MathWorks). Instrumentresponse functions
(IRFs) were recorded in a solution of ATTO 488-CA or ATTO 655-CA in
near-saturated centrifuged potassium iodide at a 25-kHz average count rate.
Macrotime-dependentmicrotime shiftingwaspresent andcorrected for two
(blue/parallel and red/perpendicular) of four avalanchephotodiodes (APDs)
on the instrument response function (IRF) data. Signals from each TCSPC
channelweredivided in timegates todiscern483-nmexcitedFRETphotons
from 635-nm excited acceptor photons. A two-colorMFD all-photon burst
search algorithm (46) using a 500-ms sliding timewindow (minimum of 50
photons per burst,minimumof 5 photons per timewindow) andakernel
density estimator (ALEX-2CDE < 12) were used to identify single donor-
acceptor–labeled molecules in the fluorescence trace.
Multiparameter graphs
Per single molecule, a number of parameters were calculated. The
corrected FRET efficiency was calculated as follows
E ¼ FBR  aFRR  bFBB
FBR  aFRR  bFBB þ gFBB ð8Þ10 of 14
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 where FBR = SBR − BBR is the background (BBR)–corrected number
of photons in the red detection channel after blue excitation, FBB =
SBB − BBB is the background (BBB)–corrected number of photons in
the blue detection channel after blue excitation, and FRR = SRR –
BRR is the background (BRR)–corrected number of photons in the
red detection channel after red excitation. a is a correction factor
for direct excitation of the FRET acceptor with the blue laser, b is a
correction factor for cross-talk of the FRET donor in the red detec-
tion channel, and g corrects for the differential detection efficiency
in the blue and red detection channels.
The corrected stoichiometry was calculated as follows
S ¼ FBR  aFRR  bFBB þ gFBB
FBR  aFRR  bFBB þ gFBB þ FRR ð9Þ
An invariant S parameter confirms a constant microscope and dye
performance.
FRET donor lifetimes tD(A) and FRET acceptor lifetimes tA were
determined using a burst-wise maximum likelihood estimator ap-
proach. Static FRET lines were calculated assuming an R0 = 53 Å, a
donor-only lifetime tD (≈3.8 ns) estimated from the experimental data
(stoichiometry > 0.8), and fastGaussian distributed dye linker dynamics
over 6 Å. Dynamic FRET lines were calculated using handpicked ex-
treme state lifetimes as a reference.
The FRET donor anisotropy rD and FRET acceptor anisotropy rA
were calculated from the burst-wise intensities in the different polariza-
tion channels. The anisotropy versus fluorescence lifetime plots were
fitted with a Perrin equation
r ¼ r0=ð1þ t=qÞ ð10Þ
where r is the single-molecule anisotropy, r0 = 0.4 is the fundamental
anisotropy, t is the single-molecule fluorescence lifetime, and q is the
single-molecule rotational correlation time.
Photon distribution analysis
Static PDA was carried out to obtain the absolute interdye distance
distribution as described before, assuming two (or more) Gaussian dis-
tributed states (47). Dynamic PDA was carried out to obtain additional
insights into conformational interconversion kinetics between these
states, as described before (48). Practically, for each FRET data set,
raw bursts were rebinned in different time bins (0.2, 0.5, 0.75, and
1 ms), and four histograms were constructed and analyzed simulta-
neously. Data were plotted in a FRET efficiency versus stoichiometry
plot to deselect bins with complex acceptor photophysics, and only bins
with at least 20 andmaximally 250 photons (to reduce calculation time)
were used for PDAanalysis. A three-statemodel for aGaussian distance
distribution (47) was used to generate a library of simulated EPR values,
which was subsequently fitted to the experimental EPR histogram using
a reduced c2–guided simplex search algorithm. When two data sets
were compared [for example, EF-Tu(GDP) versus EF-Tu(GDPNP)],
the eight histograms were analyzed simultaneously (as exemplified in
fig. S6B): Themean andwidth of all Gaussian distributed substates were
globally optimized over all samples, whereas the state area A (static
PDA) or interconversion rate constants kopening and kclosing (dynamic
PDA)were globally optimized over a single sample.Moreover, the stan-
dard deviation s of the distance distributions was globally optimized at
a fraction F of the corresponding distance to increase fitting robustness,Talavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018which has been shown before to be reasonable for FRET experiments
with a blinking FRET acceptor (49, 50). Finally, F was globally opti-
mized over all states and data sets. We first validated this global fitting
approach experimentally with a data set of nine conformationally static
double-stranded DNAmolecules with different D-A spacing (fig. S6, C
and D). In summary, for a comparative analysis of two samples, only
10 parameters were needed to be optimized (R1,R2,Rstatic, F, 2 × k12, 2 ×
k21, and 2 ×A3). R is the FRET-averaged donor-acceptor distance 〈RDA〉E
(50). A probability density function (PDF) was calculated per state using
the R and s parameters obtained from PDA analysis that describe the
underlying Gaussian distributed states. The summed PDF was scaled
to a total area of unity, with the PDF area of each state scaled to the
corresponding fraction of molecules. Criteria for a good fit were a low
(<3) reduced c2 value, as well as a weighted residuals plot free of trends.
The relative 95% confidence intervals of the interconversion rate con-
stants were calculated to estimate parameter determination robustness
andwere typically smaller than 25% for k values > 0.25 s−1. The resulting
dwell times are presented as the average ± SD of at least three
independent measurements originating from at least two protein puri-
fication batches. Correction parameters for PDA analysis were the av-
erage background count rates in donor and acceptor channels after
donor excitation, donor cross-talk (b = 0.01), and the relative detection
efficiency of donor and acceptor (g = 0.69), both determined as de-
scribed previously (45, 51). Furthermore, we used a Förster radius
of R0 = 53 Å that was calculated using the measured dye spectra, an
orientation factor k2 = 2/3, a measured quantum yield F = 0.62 for
ATTO 488, and an extinction coefficient e = 265,000 M−1 cm−1 for
Alexa Fluor 647. The quantum yield was determined using a homebuilt
absorbance/fluorescence spectroscope (52).
spFRET simulation experiment to verify the range of
interconversion rate constants
Details on the simulations: Simulation time was 2000 s in a 5-mm3 box
containing 10 molecules diffusing at D = 1 mm2/s and a point spread
function lateral waist wr = 200 nm and axial waist wz = 1000 nm.
Fluorescence lifetimes and anisotropy were also simulated. During
simulations, dye linkers were allowed to fluctuate over 5 Å. This av-
erages out in a burst but is visible in the fluorescence lifetime. D-A
distances were distributed Gaussian with a width s = 5 Å, and a 10-ms
static distance distribution rearrangement time was allowed. Simula-
tions were performed at two signal-to-noise (SNR) ratios: high (to test
whether the PDA fitting works in principle) and low (representative
for the actual experiments) (table S5). Between k = 0.15 and 10/ms,
dynamic PDA recovered the input parameters very well. Accuracy
was marginally lower at low SNR (fig. S6 and table S6). In addition,
the ratio of k values had to be <10 to allow significant population of
each state.
Crystallization and structure determination
For crystallization, nucleotide-free pEF-TuT382, EF-TuT61E, or EF-
TuT382E (1 mg/ml) was mixed and incubated for 20 min at 37°C with
100mMGDP, GTP, GTPgS, or GDPNP to prepare the different nucle-
otide complexes. Afterward, the samples were concentrated to approx-
imately 10 mg/ml and filtered before use in the crystallization setup.
Conditions were screened using a mosquito HTS robot from TTP
Labtech (http://ttplabtech.com/).
Crystals of pEF-TuT382 in complex with GDP grew after a few days
in 0.2 M NaCl, 0.1 M MES (pH 6.5), and 10% PEG4000 (polyethylene
glycol, molecular weight 4000). These crystals were cryoprotected by11 of 14
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 supplementing the mother liquor solution with 35% PEG4000 and
directly vitrified in liquid N2 before data collection and diffracted to
~2.8 Å. The crystals of the EF-TuT61E and EF-TuT382E mutants with
GDP grew in 0.1MMgCl2, 0.1 MHepes (pH 7.5), and 10% PEG4000.
The crystals of pEF-TuT382 in complex with GTP grew in 20%
PEG3550, 0.1 M bis-tris propane (pH 6.5), and 0.2 M sodium iodide.
Before data collection, these crystals were quick-soaked in 1M sodium
iodide (data collection in this case was done at 1.85 Å). For data col-
lection, crystals were supplemented with 20% glycerol and vitrified in
liquid N2.
In each case, data were processed with the XDS suite (53). In all cases,
the unit-cell contentwas estimatedwith the programMATTHEWCOEF
from the CCP4 program suite (54). Molecular replacement was per-
formed with Phaser (55). We split in individual domains the co-
ordinates of the Protein Data Bank (PDB) structure 1EFC (26) and
used them as a searchmodel for molecular replacement. Themolecular
replacement solutionswere then subjected to 30 cycles of normal refine-
ment with BUSTER-TNT (56), which included rigid body and TLS
refinement (as implemented in the RB and TLSBasic macros). In the
later stages, refinementwas implemented using the default options of the
program. In the case of the complex of pEF-TuT382 with GTP, the data
were collected at a wavelength of 1.8369 Å and the structure was solved
by MR-SAD using iodine also with Phaser (55). The crystal contained
twomolecules in the asymmetric unit, and 11 I atoms were placed with
occupancy above 90%. The initial phases were of sufficient quality to
allow automated building, performed with the ARP/wARP suite to al-
most completeness (~90% of the structure was built in this way). Struc-
ture refinement was performed with BUSTER-TNT (56) using the
default options of the program. In each case, refinement was completed
by combining manual building with Coot (57) and maximum likeli-
hood refinement as implemented in BUSTER-TNT (56) using 5% of
the reflections as a test set for cross-validation throughout the entire
process. Structure quality was checked using MolProbity. Full data col-
lection and refinement statistics are reported in table S3.
Small-angle x-ray scattering
SAXS data were collected at the SWING and BM29 beamlines [Soleil
and European Synchrotron Radiation Facility (ESRF) synchrotrons]
using the standard beamline setup in SEC mode. The different protein
samples were prepared as described above for crystallization in 25 mM
Hepes (pH 7.5), 1 mM MgCl2, 1 mM TCEP, and 40 mM NH4Cl.
Frames showing radiation damage were removed before data analysis.
The data were analyzed with the ATSAS suite (58).
For SEC-coupled SAXS data collection, we used a Shodex KW402.5-
4F column coupled to a high-performance liquid chromatography
(HPLC) system, in front of the SAXS data collection capillary, to
separate the excess noncomplexedmaterial and thus remove this source
of background. A flow rate of 0.2 ml/min was used, and the data were
collected at 15°C. Rg values were obtained from the Guinier approx-
imation and the Io by extrapolation to q = 0, as implemented in the
ATSAS suite. This data collection strategy was extensively used to ef-
ficiently remove aggregates (which are a major problem for SAXS)
while also allowing the collection of hundreds of scattering curves
from the SEC peak that contains the sample of interest and a nearly
perfect match with the reference buffer. The scattering curves, which
cover a range of concentrations, were then compared and averaged to
obtain the final data.
SAXS-based models were, in all cases, derived from the coordinates
of crystal structures. The coordinates of each initial model were com-Talavera et al., Sci. Adv. 2018;4 : eaap9714 14 March 2018pleted to account formissing loops and side chains usingModeller (59).
Furthermore, all SAXS models were relaxed by molecular dynamics
equilibration at 300K (see below for further details), and sampling from
the trajectory generated an initial ensemble of a few thousand models.
We then used EOM (Ensemble Optimization Method) (60) and MES
(Minimal Ensemble Search) (61) to select from this pool of structures
the minimal ensembles with the best agreement with the experimental
SAXS scattering curves. Figure S2 shows each ensemble together with
the fitting of the calculated scattering curve from each ensemble to
the experimental SAXS data. The calculation of ab initio shapes
based on the scattering data was done with the program DAMMIF
from the ATSAS package (58). Table S4 shows all the SAXS-derived
parameters.
Molecular dynamics simulations
The crystal structures of the EF-Tu–GDP (1EFC) and EF-Tu–GNP
(1EXM) complexes were used as starting models for the simulation of
EF-Tu in the open and closed conformations. The missing atoms from
these structures were modeled using the program Modeller (62). The
THP2NAMD (63) patch was used to generate the different phosphoryl-
ated models. Furthermore, the GDP and GNP molecules were parame-
terized using the SwissParam server (www.swissparam.ch/).
The initial models were subjected to a conjugate gradient energy
minimization in vacuumwith the Ca restrained and then freed in a sec-
ond minimization step. The complexes were then embedded in a water
box, and electric neutrality was achieved by adding Na+ counter ions at
150mM. The whole systemwas again energy-minimized in 3000 steps.
Themolecular dynamics simulationwas carried out for 1 nswith the
programNAMD2.7 (63) at constant temperature (310 K) and constant
pressure (1 atm), with periodic boundaries and using CHARMM36 as
force field. A time step of 2 fs was used to integrate the equations of
motion. The short-range interactions were cut at 12 Å, and the smooth
particle mesh Ewald method was used to calculate electrostatic interac-
tions. Hydrogen atoms were constrained using the SHAKE algorithm.
The VMD suite was used for the preparation of the system and for vi-
sualization and analysis of the trajectories.
Site-directed mutagenesis
The oligonucleotides used for the construction of EF-Tu mutants are
listed in table S9. pET-His–EF-Tu derivative plasmids carrying muta-
tions were amplified using primers containing the mutations of interest
and appropriate reverse primers using a Q5 polymerase (New England
Biolabs) according to themanufacturer’s recommendations. Template
DNAwas removed byDpn I treatment, and amplified fragments were
phosphorylated using T4 PNK (New England Biolabs), ligated using
T4 ligase (New England Biolabs), and transformed into E. coliMC1061
strain. The introduced mutations and the absence of secondary muta-
tions were verified by sequencing of plasmid DNA. Plasmids were
transformed intoE. coliBL21(DE3) strain, andprotein expressionwas con-
firmed by Western blotting with antibodies against the polyhistidine-
tag (Sigma).
Sequence analysis
A manually curated sequence alignment of the EF-Tu superfamily was
retrieved from the Pfam database (64). The Pfam alignment was used as
input for the program Skylign (65) to generate Logos representing the
multiple sequence alignment and conservation of the superfamily.
Figure S11 shows Logos illustrating the degree of conservation of each
phosphorylation site.12 of 14
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